Non classé
DiCE is proud to be part of the #myUEGcommunity at UEGWeek2022
At DiCE, we strongly believe in cooperation and working together, which is why it was our pleasure to join UEG at their yearly congress in Vienna t...
Patients with Locally Advanced Mismatch Repair Deficient Colon Cancer can Benefit from Immunotherapy—the Promising Results of the NICHE-2 Clinical Trial
Encouraging results on the use of immunotherapy for patients with deficient mismatch repair colon cancer were presented at the ESMO Congress 2022 i...
Commission Unveiled New Proposed Cancer Screening Recommendations – Gastric Cancer Included for the First Time
Updated recommendation on cancer screening is based on the latest scientific advice. The new guidance updates the 2003 Council Recommendation and i...
DiCE Award Helps EuropaColon Polska Pregnancy Project Come to Life
EuropaColon Polska launches campaign for pregnant women on the risks and signs and symptoms of CRC with help from DiCE Award
...
New Normal, Same Cancer Campaign Continues
New Normal, same Cancer campaign continues – with specific materials on certian tumour types also now available
...
Welcome to A.R.CA.D – Our New French Member
Welcome to our new Member organisation A.R.CA.D from France – strengthening our collective voice in fighting digestive cancers for patients!<...
Grants to Civil Society Orgs Addressed in Collective Response to EU Consultation
DiCE adds the patient voice to the EPF response to EU Consultation – adding key point on grants to CSO’s
...
DiCE Launches Project to Educate Patients and Healthcare Professionals on Biomarkers in Colorectal Cancer
DiCE launches educational project on biomarkers – Colorectal cancer: getting personal can be lifesaving
...